桂林三金：公司目前无收购广西金嗓子的计划

Group 1 - The company, Guilin Sanjin (002275.SZ), has no plans to acquire Guangxi Jinsangzi to strengthen its respiratory system drug portfolio [2] - An investor inquired about the potential acquisition on an investor interaction platform [2] - The company responded to the inquiry on January 22, indicating the absence of any acquisition plans [2]